Related Experiment Video
Updated: May 24, 2026

05:13
Establishment of an Embryo Implantation Model In Vitro
Published on: June 21, 2024
Effects of estrogenic compounds on neonatal oocyte development
Jenna R Karavan1, Melissa E Pepling
1Syracuse University, Syracuse, NY 13244, United States.
Reproductive Toxicology (Elmsford, N.Y.)
|March 13, 2012
Summary
Environmental estrogens disrupt early mouse oocyte development, reducing primordial follicle numbers. This study investigated synthetic estrogens
Area of Science:
- Reproductive Biology
- Developmental Biology
- Endocrinology
Background:
- Oocytes develop within germline cysts, a process involving significant oocyte death.
- Environmental estrogens can negatively impact female reproductive potential by altering oocyte development.
- Primordial follicles are crucial for future reproduction, and their numbers are established during early development.
Purpose of the Study:
- To investigate the effects of specific synthetic estrogens (diethylstilbestrol, ethinyl estradiol, bisphenol A) on perinatal oocyte development in mice.
- To determine how exposure to these compounds influences cyst breakdown, oocyte survival, and follicle development.
Main Methods:
- Neonatal female mice were exposed to low or high doses of diethylstilbestrol, ethinyl estradiol, or bisphenol A on postnatal days 1-4.
- Ovaries were analyzed on postnatal day 5 to assess developmental parameters.
- Quantification of single oocytes, oocyte number per section, and follicle activation was performed.
Main Results:
- Exposure to synthetic estrogens significantly reduced the percentage of single oocytes (from 84% in controls to 50-75%).
- An increase in oocyte number per section was observed (from 8 in controls to 12-16).
- Follicle activation was reduced, with primordial follicles increasing from 62% in controls to over 80% in most treated groups.
Conclusions:
- Perinatal exposure to synthetic estrogens like diethylstilbestrol, ethinyl estradiol, and bisphenol A disrupts normal oocyte development and cyst breakdown.
- These environmental estrogens lead to altered oocyte survival and follicle development, potentially impacting long-term reproductive capacity.
- The findings highlight the sensitivity of early oogenesis to endocrine-disrupting chemicals.
Related Concept Videos
Oogenesis
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Oogenesis
Oogenesis, the process of developing egg cells (female gametes), occurs within the ovaries and is fundamental to female fertility. This sequence begins during fetal development when diploid oogonia in the developing ovaries undergo mitotic divisions to produce primary oocytes. By birth, these primary oocytes enter prophase I of meiosis but become arrested in this stage, remaining suspended until puberty.
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is known...
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is known...
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Hormonal Control of the Ovarian Cycle
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
